|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.90 GBX | -2.37% |
|
+6.29% | +13.62% |
| 24/02 | Avacta hails new data supporting proprietary preCision platform | AN |
| 24/02 | Avacta Therapeutics Plans FAP-Exd's Clinical Trials After 'Favorable' Experimental Analysis | MT |
Transcripts
Search
No results for this search
- Stock Market
- Equities
- AVCT Stock
- News Avacta Group Plc
- Transcripts
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















